| Epithelial-to-mesenchymal and mesenchymal-to-epithelial transition in mesenchymal tumors: a paradox in sarcomas? G Sannino, A Marchetto, T Kirchner, TGP Grünewald Cancer research 77 (17), 4556-4561, 2017 | 121 | 2017 |
| Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets MC Baldauf, MF Orth, M Dallmayer, A Marchetto, JS Gerke, RA Rubio, ... Oncotarget 9 (2), 1587, 2018 | 82 | 2018 |
| Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes J Musa, F Cidre-Aranaz, MM Aynaud, MF Orth, MML Knott, O Mirabeau, ... Nature communications 10 (1), 4128, 2019 | 58 | 2019 |
| Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma A Marchetto, S Ohmura, MF Orth, MML Knott, MV Colombo, C Arrigoni, ... Nature communications 11 (1), 2423, 2020 | 40 | 2020 |
| Acute stress enhances the expression of neuroprotection-and neurogenesis-associated genes in the hippocampus of a mouse restraint model G Sannino, L Pasqualini, E Ricciardelli, P Montilla, L Soverchia, ... Oncotarget 7 (8), 8455, 2016 | 31 | 2016 |
| Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients G Sannino, A Marchetto, A Ranft, S Jabar, C Zacherl, R Alba-Rubio, ... EBioMedicine 47, 156-162, 2019 | 28 | 2019 |
| Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer G Sannino, N Armbruster, M Bodenhöfer, U Haerle, D Behrens, ... Oncotarget 7 (45), 73725, 2016 | 27 | 2016 |
| Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma M Dallmayer, J Li, S Ohmura, R Alba Rubio, MC Baldauf, TLB Hölting, ... Cell death & disease 10 (2), 116, 2019 | 26 | 2019 |
| Systematic identification of cancer-specific MHC-binding peptides with RAVEN MC Baldauf, JS Gerke, A Kirschner, F Blaeschke, M Effenberger, ... Oncoimmunology 7 (9), e1481558, 2018 | 22 | 2018 |
| CovidArray: a microarray-based assay with high sensitivity for the detection of SARS-CoV-2 in nasopharyngeal swabs F Damin, S Galbiati, S Gagliardi, C Cereda, F Dragoni, C Fenizia, ... Sensors 21 (7), 2490, 2021 | 21 | 2021 |
| Biomarkers of hippocampal gene expression in a mouse restraint chronic stress model M Ubaldi, E Ricciardelli, L Pasqualini, G Sannino, L Soverchia, B Ruggeri, ... Pharmacogenomics 16 (5), 471-482, 2015 | 20 | 2015 |
| Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma B Shannan, J Matschke, H Chauvistré, F Vogel, D Klein, F Meier, ... European Journal of Cancer 109, 137-153, 2019 | 19 | 2019 |
| Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes P Paolini, D Pick, J Lapira, G Sannino, L Pasqualini, C Ludka, LJ Sprague, ... Pharmacogenomics 15 (6), 759-774, 2014 | 17 | 2014 |
| Focal adhesion kinase confers pro‐migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma K Steinestel, M Trautmann, EP Jansen, U Dirksen, J Rehkämper, ... Molecular oncology 14 (2), 248-260, 2020 | 16 | 2020 |
| Integrative clinical transcriptome analysis reveals TMPRSS2‐ERG dependency of prognostic biomarkers in prostate adenocarcinoma JS Gerke, MF Orth, Y Tolkach, L Romero‐Pérez, FS Wehweck, S Stein, ... International journal of cancer 146 (7), 2036-2046, 2020 | 12 | 2020 |
| Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma MF Orth, JS Gerke, T Knösel, A Altendorf‐Hofmann, J Musa, ... International journal of cancer 144 (4), 859-867, 2019 | 12 | 2019 |
| Next steps in Ewing sarcoma (epi-) genomics G Sannino, MF Orth, TGP Grünewald Future Oncology 13 (14), 1207-1211, 2017 | 7 | 2017 |
| Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets. Oncotarget 9: 1587–1601 MC Baldauf, MF Orth, M Dallmayer, A Marchetto, JS Gerke, RA Rubio, ... | 5 | 2018 |
| Oncogenic hijacking of a developmental transcription factor evokes therapeutic vulnerability for ROS-induction in Ewing sarcoma A Marchetto, S Ohmura, MF Orth, J Li, FS Wehweck, MML Knott, S Stein, ... BioRxiv, 578666, 2019 | 2 | 2019 |
| Clinical utility of a novel engineered DNA polymerase for the sensitive and reliable detection of pathogens X Lindt, R Kranaster, L Vaahtoranta, G Sannino, A Crousilles | | 2023 |
